Tempest Therapeutics (NASDAQ:TPST) Research Coverage Started at Jefferies Financial Group
Jefferies Financial Group initiated coverage on shares of Tempest Therapeutics (NASDAQ:TPST – Free Report) in a report released on Thursday morning, Briefing.com reports. The brokerage issued a buy rating and a $15.00 target price on the stock. Separately, HC Wainwright lifted their target price on shares of Tempest Therapeutics from $35.00 to $47.00 and gave […]
More Stories
What Startups Need to Know Before Building Their First Software Product
You have a good idea for a software product. If you are an entrepreneur and startup founder, you are eager...
TreeHouse Foods, Inc. (NYSE:THS) Stock Position Raised by Northern Trust Corp
Northern Trust Corp lifted its holdings in shares of TreeHouse Foods, Inc. (NYSE:THS – Free Report) by 5.9% in the...
The Manufacturers Life Insurance Company Acquires Shares of 55,566 Rigetti Computing, Inc. (NASDAQ:RGTI)
The Manufacturers Life Insurance Company acquired a new stake in shares of Rigetti Computing, Inc. (NASDAQ:RGTI – Free Report) in...
US Issues Huawei Chips Warning, Signaling New AI Diffusion Rule
By Catherine Yang The U.S. Department of Commerce’s Bureau of Industry and Security (BIS) on May 13 warned entities against...
Foster Dykema Cabot & Partners LLC Has $20.78 Million Position in NVIDIA Co. (NASDAQ:NVDA)
Foster Dykema Cabot & Partners LLC lifted its stake in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 1,491.3%...
Greenwood Gearhart Inc. Increases Holdings in NVIDIA Co. (NASDAQ:NVDA)
Greenwood Gearhart Inc. raised its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 3.6% during the fourth quarter, according...